Market Intelligence

The number one source for bespoke market intelligence reports for the medical and healthcare sector, gathered and analyzed by our team of experts.

  • This Short Guide from the National Audit Office summarises what the Department of Health and its arm’s-length bodies do, their costs, recent and planned developments, and what to look out for across the main business areas. The guide provides data and information on key facts, trends, Department spending, spending levels, potential years of life lost, staff and pay, staff attitudes and engagement, major programme and developments and key themes from National Audit Office (NAO) reports across NHS Services, Adult Social Care Services, Public Health and Regulation and oversight.
  • The New Care Models Programme began in March and this document comes from what vanguards have told us they want, including feedback during site visits to all systems and subsequent thematic reviews. More than 260 health and social care organisations responded to an invitation in January this year to become vanguards to develop new care models that would act as blueprints for the NHS in England and an inspiration to others. During April and May, the New Care Models team carried out two-day visits to each vanguard to understand their aims in more detail. Following these reviews, they key areas for transformation were summarised in to eight enabling areas for support, forming the basis of the work programme over the next year ...
  • The report of the independent Life Sciences Commission, initiated earlier this year by the Greater Birmingham & Solihull Local Enterprise Partnership (GBSLEP), has been published. The Commission has looked at how Greater Birmingham can draw on its particular strengths to grow the life sciences sector for the benefit of patients and the economy. The Commission has highlighted Greater Birmingham’s potential to become a world-leading location for the rapid assessment of new drugs, diagnostics and devices. This includes a leading role in developing new models for accelerated clinical trials, which are providing patients with blood cancers with earlier access to new drugs, at no cost to the NHS. The Commission has identified a number of areas where local partners, in conjunction with the Government and industry, need to work together to unlock Greater Birmingham’s potential and also recommends investment in patient data systems, education & training, and support for small businesses looking to enter the life science and healthcare markets.
  • This document provides an overview of the main approaches to the organisation of wound care within homecare settings across Europe with case exemplars from England, Germany and the Nordic Countries. By identifying possible barriers to best practice wound care in home care settings and uncovering the preconditions needed to provide safe and high quality care for wound patients and support for their families, the authors provide a list of minimum recommendations for the treatment of patients with wounds in their own homes.
  • The life sciences industry in the UK has a crucial role in contributing to growth and the delivery of better healthcare for patients throughout the UK. The information in this report contributes to our understanding of the composition of this diverse sector. It provides us with an estimate of the number, type and geographical distribution of companies across the medical technology, medical biotechnology, pharmaceutical and industrial biotechnology sectors. This is the sixth annual report that analyses the information contained in the Bioscience and Health Technology ...